Imprinted genes play important roles in embryonic growth and development as well as in placental function. Many imprinted genes acquire their epigenetic marks during oocyte growth, and this period may be susceptible to epigenetic disruption following hormonal stimulation. Superovulation has been shown to affect growth and development of the embryo, but an effect on imprinted genes has not been shown in postimplantation embryos. In the present study, we examined the effect of superovulation/in vivo development or superovulation/3.5dpc (days post-coitum) embryo transfer on the allelic expression of Snrpn, Kcnq1ot1 and H19 in embryos and placentas at 9.5 days of gestation. Superovulation followed by in vivo development resulted in biallelic expression of Snrpn and H19 in 9.5dpc placentas while Kcnq1ot1 was not affected; in the embryos, there was normal monoallelic expression of the three imprinted genes. We did not observe significant DNA methylation perturbations in the differentially methylated regions of Snrpn or H19. Superovulation followed by embryo transfer at 3.5dpc resulted in biallelic expression of H19 in the placenta. The expression of an important growth factor closely linked to H19, Insulin-like growth factor-II, was increased in the placenta following superovulation with or without embryo transfer. These results show that both maternally and paternally methylated imprinted genes were affected, suggesting that superovulation compromises oocyte quality and interferes with the maintenance of imprinting during preimplantation development. Our findings contribute to the evidence that mechanisms for maintaining imprinting are less robust in trophectoderm-derived tissues, and have clinical implications for the screening of patients following assisted reproduction.
INTRODUCTION
Imprinted genes are expressed monoallelically in a parent-of-origin specific manner. To date, 96 imprinted sequences have been identified in the mammalian genome (reviewed in 1). These genes have been shown to play important roles in embryonic growth and development, placental function and postnatal behavior (reviewed in 2 -4). The aberrant expression of imprinted genes has been implicated in the development of several human disorders, including Beckwith-Weidemann syndrome, Prader-Willi and Angelman syndromes, as well as cancer (reviewed in 5).
Genomic imprinting is controlled by epigenetic mechanisms, as DNA sequence alone cannot distinguish between parental alleles or control the allele-specific expression of genes. Among known epigenetic modifications, the best characterized of these is the methylation of cytosine residues in DNA. Many imprinted genes have a differentially methylated region (DMR), with sex-specific methylation patterns inherited from the gametes (6) (7) (8) . In addition, DNA methylation is a both reversible and heritable modification that can be stably maintained after cell division.
Methylation patterns required for genomic imprinting undergo dynamic regulation during mammalian development. Patterns present in the mature gametes must be maintained throughout the life of the organism following fertilization, with the exception of cells in the germline. In the mouse, it has been shown that methylation patterns are almost completely erased in the germline by 13 .5dpc (days postcoitum), around the time the germ cells enter the genital ridge (9 -13) . These patterns must then be re-established in the developing embryo in a sex-specific manner. The establishment of methylation at imprinted genes occurs at different times in the male and female germlines. In the female germline, methylation acquisition at imprinted loci begins postnatally, during the oocyte growth phase (9,14 -17) . Acquisition of methylation patterns begins early in the oocyte growth phase, and occurs throughout oocyte growth. Methylation is acquired in a locus-specific manner, with some genes achieving their full methylation status only very late in oocyte growth (15 -17) . Since imprint acquisition occurs over a relatively long period of time, concerns have been raised that the establishment of maternal imprints may be susceptible to perturbation.
The use of exogenous gonadotrophins to synchronize and/or induce ovulation has been used in both research models and as a part of fertility treatments in women. However, these hormonal treatments may force oocytes to undergo the growth and maturation phases too rapidly. As such, the acquisition of methylation imprints may be perturbed in oocytes undergoing superovulation. Previous studies have shown that superovulation results in delayed embryo development, decreased implantation rates and increased postimplantation loss (18 -21) . A few studies have examined the effect of superovulation on DNA methylation and imprinting in the oocyte or the embryo. An initial study showed an increase in aberrant 5-methyl-cytosine staining in two-cell embryos (22) . Recently, an examination of the methylation of the DMRs of three maternally imprinted genes (Peg1, Kcnq1ot1 and Zac) in oocytes found no difference in the acquisition of imprints at these loci following superovulation. In contrast, an increase in methylation at the DMR of the paternally methylated gene H19, which is normally unmethylated in oocytes, was observed (8) .
In this study, we investigated the impact of superovulation followed by in vivo development on the acquisition and/or maintenance of imprinting in the embryos and placentas collected at 9.5 days of pregnancy in the mouse. In addition, to understand the contribution of the superovulated uterus to changes in imprinted gene expression, we performed embryo transfer experiments. We provide evidence that events occurring prior to fertilization or during the preimplantation period, such as hormonal stimulation or its subsequent effects on the uterine environment, can affect imprinted genes much later in development.
RESULTS
Effects of superovulation/in vivo development on the growth or development of 9.5dpc embryos Following superovulation, female mice were mated and embryos were allowed to develop in vivo to midgestation (9.5dpc). There was no difference in the percentage of viable embryos between control and superovulated matings; however, there was an increase in the number of embryos undergoing resorption following superovulation (KruskalWallis test, control versus superovulated, P , 0.05; Table 1 ). There was also an increase in the percentage of delayed embryos following superovulation (Fisher's exact test, control versus superovulated, P , 0.001; Table 1 ), but there was no difference in the percentage of embryos having gross abnormalities (Table 1) . The average crown-rump length of control embryos was 2.73 + 0.09 mm, which was not significantly different from that of embryos from 
Superovulation/in vivo development causes biallelic expression of Snrpn in postimplantation placentas
In order to examine the effect of superovulation on the expression of imprinted genes, RNA was extracted from embryo and placenta tissues and cDNA was generated, followed by allele-specific expression analysis. Four genes were assayed, the maternally methylated genes Snrpn and Kcnq1ot1 (or Lit1), and the paternally methylated gene H19 as well as Igf2, which shares a DMR with H19. These genes have well-defined DMRs which have been shown to have gamete-specific differences in methylation (6, 23) . Snrpn is normally expressed only from the paternal allele, owing to methylation of the maternal allele during oogenesis (24) . We defined samples having 10% or less expression from the normally silent maternal allele as being monoallelic. Using this criterion, the proportion of embryo samples with biallelic expression of Snrpn following superovulation was 13.8% ( Fig. 1B and Supplementary Material, Table S1B), which is not significantly different from control embryos (6.5%; Fig. 1A and Supplementary Material, Table S1A ). In the placenta, biallelic expression of Snrpn was observed in 3.2% of the control placentas ( Fig. 1C and Supplementary Material, Table S1A), but there was a significantly higher proportion of samples with biallelic expression in the placentas from superovulated females (37.8%, Fisher's exact test, control versus superovulated, P , 0.001; Fig. 1D and Supplementary Material, Table S1B ). These results show that the imprinted paternal expression of Snrpn in the placenta is susceptible to disruption by superovulation.
Superovulation/in vivo development does not affect the expression of Kcnq1ot1
Kcnq1ot1 is an intronic paternally expressed antisense RNA within a large imprinting cluster on mouse chromosome 7. This region is syntenic to human chromosome 11p15.5, which contains the Beckwith -Weidemann causative region. Expression of Kcnq1ot1 is regulated by maternal methylation of a 2 kb region termed the KvDMR within intron 10 of the Kcnq1 locus (25) . Methylation of the KvDMR is also important for the imprinted expression of several other genes in the cluster, including Tssc3, Cdkn1c, Kcnq1 and Ascl2 (26, 27) . We determined whether samples exhibited monoallelic or biallelic expression of Kcnq1ot1 using a qualitative assay. Following superovulation, the expression of Kcnq1ot1 was unchanged in both embryos and placentas ( Fig. 2 and Supplementary Material, Tables S1A and B). These results suggest that the establishment and maintenance of imprinted expression of Kcnq1ot1 in the placenta is more resistant to disruption by superovulation than is Snrpn.
Superovulation/in vivo development results in biallelic expression of H19 in postimplantation placentas
The paternally methylated gene H19 is normally expressed strictly from the maternal allele. The imprinted expression of H19 is the result of paternal methylation marks that are established during spermatogenesis and maintained through early embryogenesis (28) . The expression of H19 was biallelic in 19.4% of control ( Fig. 3A and Supplementary Material, Table S1A), and 13.5% of superovulated embryos ( and Supplementary Material, Table S1B ). However, in the placenta, none of the control samples exhibited biallelic expression ( Fig. 3C and Supplementary Material, Table S1A), whereas 64.1% of the placentas from superovulated females expressed H19 from both alleles ( Fig. 3D and Supplementary Material, Table S1B ). This represents a highly significant increase in the proportion of placentas with biallelic expression of H19 following superovulation (Fisher's exact test, control versus superovulated, P , 0.001). These results indicate that the paternal expression of H19 in the placenta is susceptible to perturbation by superovulation.
Superovulation/in vivo development does not affect allelic expression of Igf2
As we observed an increase in the proportion of placenta samples with biallelic expression of H19 following superovulation/in vivo development, we examined the allelic expression of Insulin-like growth factor-2 (Igf2). Igf2 and H19 share a DMR, which acts as a methylation-sensitive boundary element. In the absence of methylation on the maternal allele, CTCF binding at the DMR prevents the Igf2 promoter from accessing enhancer elements located downstream of H19, resulting in strictly paternal expression of Igf2. We did not observe a difference in the proportion of samples having biallelic expression of Igf2, as strictly monoallelic expression was observed in almost all the samples (Supplementary Material, Tables S1A and B).
Superovulation/in vivo development does not affect the methylation of the Snrpn and H19 DMRs
To determine if the biallelic expression of Snrpn or H19 was due to a loss of methylation at their respective DMRs, bisulfite conversion and sequencing was undertaken using selected embryos and placentas from the previous experiments. Superovulated samples were selected to represent different combinations of biallelic and monoallelic expression in the embryo and placenta for both genes. Given the many different permutations of these criteria, and the technical difficulty of bisulfite sequencing, four superovulated samples were selected Bisulfite sequencing analysis of the Snrpn DMR of control ( Fig. 4A ) and superovulated ( Fig. 4B ) embryos and placentas revealed that methylation was not affected following superovulation. Similarly, for the H19 DMR, bisulfite sequencing analysis of control ( Fig. 5A ) and superovulated ( Fig. 5B ) embryos and placentas showed that methylation was not affected by the administration of exogenous hormones. Although subtle effects would not be detected using the bisulfite sequencing assay, the results suggest that the loss of imprinted expression of these two genes was unlikely to be the result of a notable or significant loss of methylation in the regions examined.
The overall methylation at the Snrpn and H19 DMRs is lower in the placenta than in the embryo From the DNA methylation data described above, it was noted that the methylation of DMRs in the placenta appeared to be less complete than in the embryo. The maternal allele of Snrpn was highly methylated (94% of CpGs methylated) in all six embryos examined, while in the placenta, the methylation levels were somewhat lower (85% of CpGs methylated). Similarly, for the paternal allele of H19, the levels of methylation appeared to be higher in the six embryos (90% of CpGs methylated) than in the placentas (78% of CpGs methylated). There was no observable difference in the levels of methylation on the unmethylated alleles for either gene. These data suggest that methylation in the placenta may not be subject to the same tight regulation as in the embryo.
Effects of embryo transfer of superovulated blastocysts on overall growth or development of the embryos
Since the embryos in the previous experiment developed in vivo, we undertook embryo transfer experiments to alleviate possible effects of the environment and/or litter size (Table 1) . Ten or fewer blastocysts were transferred to each uterine horn, in an attempt to more closely model the normal litter size for CD1 mice. Each recipient received embryos from a single donor female.
The blastocysts transferred to pseudopregnant CD1 females from superovulated females exhibited a significant decrease in implantation rate when compared to control donors (t-test, control versus superovulated, P , 0.05; Table 2 ), as well as an increase in the number of embryos with delayed development (Fisher's exact test, control versus superovulated, P , 0.05; Table 2 ). There was no difference in the percentage of embryos that were viable, or in the percentage of implantation sites that were undergoing resorption. There was also no difference in the number of embryos with gross abnormalities; although this number was quite high in both groups ( Table 2 ). The average crown-rump length of control embryos was 4.21 + 0.31 mm, which was not significantly different from that of embryos from superovulated mothers (3.77 + 0.23 mm). However, the overall development of the embryos, as assessed by somite number, was affected by superovulation and embryo transfer (30.92 + 1.94 for control 
Monoallelic expression of Snrpn is not affected by superovulation and embryo transfer
Following embryo transfer, allele-specific expression analysis revealed that Snrpn was expressed biallelically in 8.7% of naturally cycling control embryos ( Fig. 6A and Supplementary Material, Table S2A ) and in 18.8% of superovulated embryos ( Fig. 6B and Supplementary Material, Table S2B ). This apparent increase of biallelic expression following superovulation and embryo transfer was not statistically significant. Similarly, in the placenta, biallelic expression of Snrpn was observed in 26.1% of control placentas ( Fig. 6C and Supplementary Material, Table S2A ) and in 37.5% of superovulated placentas ( Fig. 6D and Supplementary Material, Table S2B ); this difference was not statistically significant.
Superovulation and embryo transfer result in biallelic expression of H19 in the placenta
Following embryo transfer, biallelic expression of H19 was observed in 29.2% of embryos following transfer of control blastocysts ( Fig. 7A and Supplementary Material, Table S2A ) and of 39.4% of embryos following transfer of blastocysts collected from superovulated donor females ( Fig. 7B and Supplementary Material, Table S2B ). There was no statistically significant difference between the groups. However, biallelic expression of H19 was observed in 26.1% of placentas following transfer of control blastocysts ( Fig. 7C and Supplementary Material, Table S2A ) and in a significantly higher proportion of placentas (58.1%) following transfer of blastocysts from superovulated donors ( Fig. 7D and Supplementary Material, Table S2B, Fisher's exact test, control versus superovulated, P , 0.03). These results suggest that the imprinted expression of H19 in the placenta is particularly susceptible to perturbation.
Superovulation results in increased levels of Igf2 expression in the placenta
We examined the effect of superovulation on the total expression of an important growth factor, the Insulin-like growth factor-II (Igf2) gene in the placenta. Igf2 expression in the placenta is critical for both placental and fetal growth (29) , as it regulates the development of the diffusional permeability capacity of the placenta (30). While we did not observe any differences in the total levels of Igf2 expression in the embryos (data not shown), expression of Igf2 in placentas was increased following superovulation after both in vivo development and embryo transfer (n ¼ 14 placentas for the in vivo control group, n ¼ 15 placentas for all other groups; Fig. 8 ). This result was particularly interesting since the placenta retained strictly monoallelic expression as shown for the superovulation/in vivo development group. This result shows that superovulation can affect the placental expression of Igf2, a gene that is closely linked to H19.
DISCUSSION
Previous studies examining the effects of superovulation have largely concentrated on the growth and development of the embryo. Despite the strong association of imprinted genes with embryo growth (reviewed in 2), little has been done to investigate the possible epigenetic effects of superovulation. An investigation of 5-methylcytosine staining in two-cell mouse embryos suggested that superovulation might lead to epigenetic abnormalities in the resultant embryos (22) . Subsequently, bisulfite sequencing of DMRs of several imprinted genes in both mouse and human oocytes demonstrated both gain and loss of methylation (8) . Our approach in the current paper differs from earlier studies in extending the examination of epigenetic outcomes in the offspring of superovulated mothers to the postimplantation period and allowing imprinted genes in both the embryo and the placenta to be examined.
We have shown that superovulation followed by in vivo development results in biallelic expression of Snrpn and H19 in 9.5dpc placenta, while expression of Kcnq1ot1 was unaffected. Although several studies have shown an effect of preimplantation culture on imprinted gene expression (31) (32) (33) (34) , the expression of Snrpn has not always been examined; thus, it is possible that the imprinted expression of Snrpn is also affected by these manipulations. As the methylation pattern that confers genomic imprinting at H19 is established in the male germline (35 -38) , the biallelic expression of H19 is somewhat surprising. The administration of the exogenous hormones takes place prior to ovulation and fertilization, and was therefore expected to only affect genes that are imprinted in the female germline. Our result suggests that it is not the establishment of imprinting that is affected, but rather its maintenance. We envision two possible causes of disruption to paternal imprints. First, superovulation may result in the ovulation of abnormal oocytes, either by forcing the oocytes to develop too quickly or by rescuing oocytes that have already been selected for atresia. As a result, these oocytes may be defective in their ability to maintain imprints during the preimplantation period. The second possibility is that administration of exogenous hormones may alter the milieu of the oviduct and/or uterus, which in turn may have a negative effect on the maintenance of genomic imprinting in the conceptus. In fact, the imprinting of Snrpn was unaffected in superovulated embryos and placentas that had been transferred to an unstimulated uterus, which provides further support for an effect of hormonal milieu on the maintenance of imprinted gene expression. We cannot, however, rule out that imprint acquisition is affected by superovulation because we have only examined two of the many genes known to be methylated during oogenesis. Our group and others have previously shown that methylation imprints are acquired asynchronously during the oocyte growth phase (24, 39) . As such, genes that acquire their methylation imprints later during oocyte growth, such as Peg1, may be more susceptible to disruption by ovarian stimulation. This is also supported by the relative protection of Kcnq1ot1 to the effects of superovulation, as imprint acquisition at the KvDMR occurs relatively early during oocyte growth (39) .
As no change was seen in the expression of Kcnq1ot1 following superovulation, this suggests that superovulation may not be a major contributor to the increased incidence of Beckwith-Weidemann observed following assisted reproductive technologies (ARTs) (40) (41) (42) (43) . A small number of samples did exhibit biallelic expression of Kcnq1ot1 in the placenta following superovulation, but the matched embryos exhibited strictly monoallelic expression. However, a recent study of a small number of human oocytes collected following ovarian stimulation showed a complete loss of methylation at the KvDMR in one of the 16 oocytes analyzed (44) . Further studies will be required to elucidate the effect of superovulation on the Kcnq1ot1 locus at different stages during the reproductive cycle. While only the monoallelic expression of H19 in the placenta was affected following superovulation and embryo transfer, these results may be misleading. There was an increase in the proportion of samples that were biallelic for Snrpn in the placenta, and in the proportion of samples that were biallelic for H19 in the embryo and placenta following embryo transfer alone (embryo transfer control group). A direct comparison of the in vivo and embryo transfer groups may not be appropriate, due to the difference in approach taken. However, these results suggest that the embryo transfer procedure can perturb imprinted gene expression, and that further study is required. There are many aspects of the embryo transfer procedure that could cause disruption of imprinted gene expression, such as the flushing of blastocysts from the uterus and/or embryo culture. A recent study has shown that the embryo transfer procedure alone results in loss of imprinting at several loci in both the placenta and the yolk sac at 9.5dpc, with more severe effects when embryo culture preceded the embryo transfer (45) . Additionally, preimplantation culture has been shown to have an effect on the expression of several imprinted genes (31 -34) . Although these studies examined the consequence of longer exposures to culture media, an effect due to shorter culture times cannot be ruled out. Furthermore, the blastocysts are transferred to a uterus that is delayed by 1 day relative to the donors. Although the recipients are naturally cycling females, the uterine milieu will not be synchronized with the donor embryos, and this may affect the embryo. All of these features of embryo transfer may contribute to the biallelic expression of imprinted genes. The monoallelic expression of imprinted genes in the placenta appears to be particularly susceptible to perturbation. Loss of imprinting at H19 was observed specifically in the placenta following preimplantation culture in Whitten's media (34) . In a subset of placentas from embryos cultured in Whitten's media, biallelic expression of Snrpn was also observed (34) . Here, we have shown loss of imprinting at both Snrpn and H19 in the placenta following superovulation. These results suggest that maintenance of imprinting is regulated differentially in the embryo and in the placenta. As previously discussed by Mann et al. (34) , there are several possible reasons why trophectoderm-derived tissues might be more susceptible to epigenetic disruption. One potential reason for the increased effect seen in placentas is that the trophectoderm cells are the outer cells of the blastocyst and are therefore in direct contact with the environment. We have observed that the disruption of Snrpn imprinting following superovulation is slightly more pronounced in the placenta, which may be a result of these cells being in direct contact with an altered uterine milieu. A second possibility is that there is less redundancy in epigenetic modifications in the placenta. Some groups have suggested that imprinting in the placenta is regulated primarily by histone modifications, and that methylation does not play an important role in imprinted gene expression in this tissue (46, 47) . This may be supported by our observation that the overall levels of methylation at the DMRs of both Snrpn and H19 appear to be lower in placentas than in embryos, without an effect on the monoallelic expression of these genes. However, as the normal patterns of methylation of Snrpn and H19 have not been well characterized in the placenta, further studies are required.
We did not observe changes in the methylation at either of the DMRs examined following superovulation, despite the appearance of biallelic expression. The regions we have examined are known to acquire methylation during gametogenesis (24) and therefore are important for the initial establishment of imprinted expression. In the mouse, the DMR of H19 is approximately 2.0 kb long, and methylation is also observed in the promoter region located upstream of the DMR (48 -50) . We have only examined a region of approximately 420 bp within the DMR, which includes two of the four CTCF binding sites (6) . As such, it is possible that methylation in a different region of the DMR is of greater importance for the maintenance of imprinting during postimplantation development. Alternatively, it may not be overall levels of methylation that are important for maintaining imprinted expression. Rather the methylation of specific CpG dinucleotides might be of key importance, such as binding sites for proteins like methyl CpG-binding protein which may then recruit other proteins involved in chromatin modifications (reviewed in 51). Similarly, the DMR1 of Snrpn is 6.6 kb in length. We have examined a region of approximately 430 bp within DMR1 (6), and therefore cannot conclude that methylation is not affected at all, or if the observed biallelic expression has occurred in the absence of any methylation changes. A recent study showed that for several imprinted genes, including Snrpn, tandem repeats outside the DMR1 region are important for the maintenance of imprinted expression. These regions also become methylated when part of an imprinted transgene and this methylation is maintained throughout preimplantation development (52) . This supports the idea that regions other than those known to be important for imprint establishment are required for maintaining imprinting. Finally, we are proposing that maintenance of DNA methylation is affected by superovulation. Thus, failure to maintain imprints due to compromised oocyte quality could occur at any time during preimplantation development, affect only a subset of blastomeres and be difficult to detect using bisulfite sequencing.
Previous studies which focused on the growth and development of embryos showed that superovulation resulted in smaller embryos by weight (20, 21) . Developmental delay following superovulation and embryo transfer have also been reported (20, 21) . However, in our current study, we did not observe an effect on embryo size or somite number following superovulation/in vivo development. In the previous studies, embryo size was assessed at 18dpc or at 14dpc, respectively, whereas we have assessed size at 9.5dpc. Although we have not seen any effects on the growth of the embryo, this may be due to the early time point examined. Prior to 9.5dpc, it is thought that the placenta does not play a critical role in supporting the embryo (53 -56). As we are examining embryos prior to this critical period, it may be too early to observe defects of growth.
As the primary effect of superovulation on imprinted genes appears to be in the placenta, we have also examined the expression of Igf2, a critical factor in placental growth and nutrient transfer to the placenta. Following superovulation, the expression of Igf2 was increased in both the in vivo and embryo transfer groups despite the fact that Igf2 expression was monoallelic in the placenta following in vivo development. Elevated levels of Igf2 in the placenta have been correlated with fetal growth restriction in humans (57) and sheep (58) and with early embryonic lethality of somatic cell nuclear transfer derived cows (59) . Little is known about mechanisms regulating the total levels of Igf2 expression in the placenta. It is known that the expression of Igf2 in the labyrinthine trophoblast occurs exclusively from a placenta-specific promoter (P0) (29, 60) . In the other placental cell types, Igf2 is expressed from the fetal promoters, P1, P2 and P3 (29, 61) . All of these promoters result in an identical protein; however, the presence of multiple promoters with differential usage dependent on cell type suggests that regulation of Igf2 expression in the placenta is complex.
Even in the absence of methylation changes, the biallelic expression of imprinted genes is the cause for concern. Several studies have shown postnatal phenotypes as a result of disruption of imprinted genes during early development. Ecker et al. (62) demonstrated that preimplantation culture in either KSOM or Whitten's media resulted in behavioral changes, increased anxiety and deficits in spatial memory in adult mice. Embryo culture in the presence of fetal calf serum was shown to affect the expression of several imprinted genes, but also to result in increased weight, locomotor deficits, organomegaly and increased anxiety in adult mice (63) . In addition to mouse models, patients with BeckwithWeidemann Syndrome, which is often associated with alterations in imprinted gene expression, are more susceptible to neoplasia (64) . Several groups have raised concerns about the association of rare imprinting diseases with ARTs, including ovarian hyperstimulation (16, 65) . Analyses of affected children have consistently shown methylation defects at the DMRs of SNRPN (Angelman Syndrome), KCNQ1OT1 (Beckwith -Weidemann Syndrome) and most recently PEG1/MEST (Silver -Russell Syndrome) (40 -43,66,67) . While we did not observe changes in methylation at the DMRs examined in this study, we must also consider the possibility of long-term effects as a result of biallelic expression of imprinted genes.
In this study, we have shown that superovulation results in biallelic expression of two imprinted genes, Snrpn and H19, and the increased expression of an important growth factor, Igf2, in the postimplantation period. Our results, and those of Mann et al. (34) , demonstrate that trophectoderm-derived tissues are more susceptible to disruption of imprinted genes than the embryo proper. These results lead us to suggest that placental tissue from babies born following ARTs may be used to screen for epigenetic disruption. Early screening using this tissue may lead to earlier intervention or better surveillance of children who may be at risk later in life.
MATERIALS AND METHODS

Embryo collection and mice
Embryos and placentas were obtained from crosses of CD1 female mice (Charles River Canada, St Constant, QC, Canada) to C57Bl/6J (CAST7) male mice (68) , to allow for the identification of alleles. Eight-week-old CD1 female mice were superovulated by injection of 5 IU of pregnant mares' serum gonadotropin (Sigma) and 5 IU human chorionic gonadotropin (Sigma). The presence of a vaginal plug was designated at 0.5dpc. Embryos and placentas were collected at 9.5dpc. For embryo transfer experiments, females were superovulated and mated to C57Bl/6J (CAST7) males, as above. Embryos were collected at 3.5dpc into HEPESbuffered KSOM, and were then immediately transferred to 2.5dpc pseudopregnant CD1 females as described (69) . Embryos and placentas were collected at 9.5dpc relative to the recipient female. Embryos and placentas were bisected transversely to allow for DNA and RNA extraction from the same embryo. Experiments were performed in compliance with guidelines established by the Canadian Council for Animal Care.
RNA isolation and allele-specific expression assays RNA was isolated from one half of bisected embryos or placentas using the HighPure RNA Tissue Kit (Roche Molecular Biochemicals), with minor modifications to the manufacturer's protocol. cDNA synthesis was performed using SuperScriptII (Invitrogen), random hexamers (Invitrogen) and 80 ng of total RNA. Allele-specific H19 and Snrpn LightCycler (LC) expression assays were carried out on cDNA using a LC RealTime PCR System (Roche Biochemicals). The H19 LC assay was performed as described previously (68, 70) , except that 1 ml of cDNA was used. The Snrpn LC assay was performed as described (68) , without the addition of DMSO and with 1 ml of cDNA. After background subtraction, the relative contribution of each allele was calculated as the peak area of the melting curve generated at the allele-specific temperature.
Kcnq1ot1 expression assay. The Kcnq1ot1 expression LightCycler assays were performed on cDNA prepared as above. The Kcnq1ot1 primers, LitLC-F (5 0 -GAGGCTCAGGTCTC TGTTGG-3 0 ) and Lit1LC-R (5 0 -TTACAGCGGAAAGCACT CCT-3 0 ) were used to amplify a 311 bp region of the Kcnq1ot1 region (AF119385; 71). Fluorescent resonance energy transfer hybridization probes were designed to the CD1 amplicon. The Kcnq1ot1 sensor probe (5 0 -AGAGTTG ATTTAAAGGACCAAGGCCA-FL-3 0 ; Idaho Technologies) spans a single nucleotide polymorphism at nucleotide 3939 between CD1 (T) and CAST (G) and was labeled with fluoroscein at the 3 0 end. The Kcnq1ot1 anchor probe (5 0 -RED640-GGCCCAAACCTTAGTCCTCCATTTTG-P-3 0 ) was labeled with LC-Red640 at the 5 0 end and phosporylated at the 3 0 end. To a Ready-to-Go PCR bead (GE Healthcare), 8.12 ml of H 2 O and 0.38 ml of TaqStart Antibody (BD Biosciences Clontech) were added, and the reaction was incubated at room temperature for 5 min. After incubation, 1.5 mm MgCl 2 , 0.2 mm of each primer and 0.3 mm of each probe was added to the mix and the volume brought to 12.5 ml. From this reaction mix, 10 ml was removed and placed in a LC glass capillary (Roche Molecular Biochemicals), and 1 ml of cDNA plus 9 ml of H 2 0 were added for a final volume of 20 ml. After an initial denaturation step at 958C for 30 s, amplification was performed for 35 cycles at 958C for 0 s, 608C for 15 s and 728C for 13 s. A single fluorescence acquisition occurred at the end of each annealing step. After amplification, a final denaturation and annealing step was conducted (958C for 0 s, 508C for 2 min) followed by a melting curve analysis with fluorescence acquisition occurring continuously as the temperature increased from 50 to 858C at a rate of 0.058C/s. After background subtraction, the presence or absence of each allele was determined based on the presence of peaks at the allele-specific temperature, approximately 65.58C for CAST7 and 68.58C for CD1 (LC Data Analysis Software, Roche Molecular Biochemicals).
Igf2 expression assay. Igf2 expression was performed on cDNA as above. The Igf2 primers, Igf2-F (5 0 -ATCTGTGA CCTCCTCTTGAGCAGG-3 0 ) and Igf2-R (5 0 -GGGTTGTTTA GAGCCAATCAA-3 0 ) were used to amplify a 202 bp region of Igf2 (NM 010514). To a Ready-to-Go PCR bead, 0.3 mm of each primer and H 2 O were added. After incubating for 5 min at room temperature, 1 ml of cDNA was added. After an initial denaturation step at 948C for 5 min, amplification was performed for 40 cycles at 958C for 15 s, 568C for 30 s and 728C for 30 s. One microliter of Tsp509I restriction enzyme was added to 10 -15 ml of PCR product and digestion was allowed to proceed at 658C for 2 h. The digested samples were run on a 7% acrylamide gel. The digested CD1 allele produces fragments of 178 and 24 bp, while the digested CAST7 allele produces fragments of 163, 24 and 15 bp.
DNA isolation and bisulfite sequencing
DNA was isolated from one half of bisected embryos or placentas and bisulfite treatment was carried out as previously described (6) . Nested PCR amplification of H19 and Snrpn was conducted with the same primers as previously described (6) . We examined a total of 15 CpG sites in the imprint control region (ICR) upstream of the H19 transcriptional start site (Genbank acc. no. U19619, nucleotides 1304-1726). This region includes the two 5 0 CTCF binding sites (R1 and R2), but does not include the two 3 0 CTCF binding sites (R3 and R4) (70) . We examined 16 CpG sites in the exon 1 region of Snrpn (Genbank acc. no. AF081460, nucleotides 2151-2570). The presence of both alleles in the PCR products was confirmed using restriction fragment length polymorphisms generated by SNPs between the CD1 and C57Bl/6J (CAST7) strains. Digestion of 5 ml of the purified PCR products [Snrpn with SwaI (NEB) and H19 with DpnII (NEB) restriction enzymes] was followed by gel electrophoresis in 1.5% agarose. For each sample, a minimum of two independent PCR products was subcloned using the TOPO TA Cloning Kit (Invitrogen), and plasmid DNA was purified using the QIAprep Spin Miniprep Kit (Qiagen). Ten to twenty clones were analyzed per PCR product, and clones containing the appropriate insert were sequenced using an ABI 3100 sequencer.
Quantification of Igf2 gene expression
Real-time quantitative RT-PCR was conducted using a two-step approach; the cDNA prepared for the allele-specific expression assays was used as the template for SybrGreen (Qiagen). The primers for total Igf2 expression were the same as those used for allele-specific expression analysis (above). Samples were analyzed in duplicate and the threshold cycle (C T ) was normalized to the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (Gapdh) (primers Gapdh-F: 5 0 -TGTTTGTGATGGGTGTGAA-3 0 and Gapdh-R: 5 0 -TCCTCAGTGTAGCCCAAGAT-3 0 ) using an MX4000 (Stratagene). The mRNA level for each sample relative to one control sample was calculated using the relative C T method.
Statistical analysis
Comparisons of litter characteristics between control and superovulated groups were first subjected to Levene's test for homogeneity of variance. For groups with equal variances, comparisons were further analyzed by one-way ANOVA, while for groups with unequal variances the comparisons were analyzed by the Kruskal-Wallis test for non-parametric data. Some groups were analyzed using Fisher's exact test, these are indicated in the text. Comparisons of allele-specific expression assay groups were analyzed using Fisher's exact test. Bisulfite sequencing groups were compared using a t-test for unpaired samples and Levene's test for equality of variances was applied using SPSS 14.0 for Windows. Comparisons of Igf2 expression levels were analyzed using the least square ANOVA and the linear mixed effect model using SAS (Cary, NC, USA).
